Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2008-06-24
2008-06-24
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
Reexamination Certificate
active
07390795
ABSTRACT:
A method for the treatment or prevention of tissue damage in a subject having an inflammatory and/or tissue damaging condition, which comprises administering to the subject an effective amount of a compound capable of inhibiting the binding of C-reactive protein (CRP) to an autologous or extrinsic ligand.
REFERENCES:
patent: 4640913 (1987-02-01), Wissner et al.
patent: 5064817 (1991-11-01), Yedgar et al.
patent: 5681829 (1997-10-01), Tempesta et al.
patent: 5811568 (1998-09-01), Bierer et al.
patent: 6764826 (2004-07-01), Yeh et al.
patent: WO 01/94951 (2001-12-01), None
patent: WO 03/013508 (2003-02-01), None
Kitao “Role of human C-reactive protein in lipid metabolism. Ingestion of CRP-lipoprotein complex by Macrophage,” Rinsho Kagaku, 1992, 21 (4) 231-234, CAPLUS abstract, AN 1993:144839.
Pepys, M.B. and Baltz, M.L. (1983) Acute phase proteins with special reference to C-reactive protein and related protein (pentaxins) and serum amyloid A protein.Adv. Immunol., 34: 141-212.
Pepys, M.B. (1996) The acute phase response and C-reactive protein. In:Oxford Textbook of Medicine, Third Ed., vol. 2 (Weatherall, D.J., Ledingham, J.G.G. and Warrell, D.A., eds.), Oxford University Press, Oxford, pp. 1527-1533.
Volanakis, J.E. and Kaplan, M.H. (1971) Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide.Proc. Soc. Exp. Biol. Med, 136: 612-614.
de Beer, F.C., Soutar, A.K., Baltz, M.L., Trayner, I., Feinstein, A. and Pepys, M.B. (1982) Low density and very low density lipoproteins are selectively bound by aggregated C-reactive protein. J.Exp. Med, 156: 230-242.
Pepys, M.B., Rowe, I.F. and Baltz, M.L. (1985) C-reactive protein: binding to lipids and lipoproteins,Int. Rev. Exp. Pathol., 27: 83-111.
Narkates, A.J. and Volanakis, J.E. (1982) C-reactive protein binding specificities: artificial and natural phospholipid bilayers.Ann. N. Y. Acad. Sci., 389: 172-182.
Volanakis, J.E. and Wirtz, K.W.A. (1979) Interaction of C-reactive protein with artificial phosphatidylcholine bilayers.Nature, 281: 155-157.
Du Clos, T.W. (1989) C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J.Immunol., 143: 2553-2559.
Pepys, M.B., Booth, S.E., Tennent, G.A., Butler, P.J.G. and Williams, D.G. (1994) Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli.Clin. Exp. Immunol., 97: 152-157.
Kindmark, C.-O. (1972) In vitro binding of human C-reactive protein by some pathogenic bacteria and zymosan.Clin. Exp. Immunol., 11: 283-289.
Fletcher, T.C., White, A. and Baldo, B.A. (1980) Isolation of a phosphorylcholine- containing component from the turbot tapeworm,Bothriocephalus scorpii(Muller) and its reaction with C-reactive protein.Parasite Immunol., 2: 237-248.
de Beaufort, A.J., Langermans, J.A.M., Matze-van der Lans, A.M., Hiemstra, P.S., Vossen, J.M. and Van Furth, R. (1997) Difference in binding of killed and liveStreptococcus pneumoniaeserotypes by C-reactive protein.Scand. J.Immunol., 46: 597-600.
Weiser, J.N., Pan, N., McGowan, K.L., Musher, D., Martin, A. and Richards, J. (1998) Phosphorylcholine on the lipopolysaccharide ofHaemophilus influenzaecontributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J.Exp. Med, 187: 631-640.
Culley, F.J., Bodman-Smith, K.B., Ferguson, M.A.J., Nikolaev, AN., Shantilal, N. and Raynes, J.G. (2000) C-reactive protein binds to phosphorylated carbohydrates.Glycobiology, 10: 59-65.
Kaplan, M.H. and Volanakis, J.E. (1974) Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J.ImmunoL, 112: 2135-2147.
Volanakis, J.E. and Kaplan, M.H. (1974) Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea-pig complement by CRP complexes: requirement for human Clq.J. Immunol., 113: 9-17.
Claus, D.R., Siegel, J., Petras, K., Osmand, A.P. and Gewurz, H. (1977) Interactions of C-reactive protein with the first component of human complement. J.Immunol., 119: 187-192.
Volanakis, J.E. (1982) Complement activation by C-reactive protein complexes.Ann. N. Y. Acad Sci., 389: 235-250.
Mortensen, R.F., Osmand, A.P., Lint, T.F. and Gewurz, H. (1976) Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis.J. Immunol., 117: 774-781.
Nakayama, S., Mold, C., Gewurz, H. and Du Clos, T.W. (1982) Opsonic properties of C-reactive protein in vivo.J. Immunol., 128: 2435-2438.
Osmand, A.P., Mortensen, R.F., Siegel, J. and Gewurz, H. (1975) Interactions of C-reactive protein with the complement system. III. Complement-dependent passive hemolysis initiated by CRP. J.Exp. Med, 142: 1065-1077.
Finland, M. and Dowling, H.F. (1935) Cutaneous reactions and antibody response to intracutaneous injections of pneumococcus polysaccharides.J. ImmunoL, 29: 285-299.
Kushner, 1. and Kaplan, M.H. (1961) Studies of acute phase protein. I. An immunohistochemical method for the localization of Cx-reactive protein in rabbits. Association with necrosis in local inflammatory lesions.J. Exp. Med, 114: 961-973.
Kushner, I., Rakita, L. and Kaplan, M.H. (1963) Studies of acute phase protein. II. Localization of Cx-reactive protein in heart in induced myocardial infarction in rabbits.J. Clin. Invest., 42: 286-292.
Gitlin, J.D., Gitlin, J.1. and Gitlin, D. (1977) Localisation of C-reactive protein in synovium of patients with rheumatoid arthritis.Arthritis Rheum., 20: 1491-1499.
Du Clos, T.W., Mold, C., Paterson, P.Y., Alroy, J. and Gewurz, H. (1981) Localization of C-reactive protein in inflammatory lesions of experimental allergic encephalomyelitis.Clin. Exp. Immunol., 43: 565-573.
Lagrand, W.K. Niessen, H.W.M., Wolbink, G-J., Jaspars, L.H., Visser, C.A., Verheugt, F.W.A., Meijer, C.J.L.M. and Hack, C.E. (1997) C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction.Circulation, 95: 97-103.
Torzewski, J., Torzewski, M., Bowyer, D.E., Frohlich, M., Koenig, W., Waltenberger, J., Fitzsimmons, C. and Hombach, V. (1998) C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries.Arterioscler. Thromb. Vasc. Biol., 18: 1386-1392.
Wolbink, G.-J., Bossink, A.W.J., Groeneveld, A.B.J., de Groot, M.C.M., Thijs, L.G. and Hack, C.E. (1998) Complement activation in patients with sepsis is in part mediated by C-reactive protein.J. Infect. Dis., 177: 81-87.
Vigushin, D.M., Pepys, M.B. and Hawkins, P.N. (1993) Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.J. Clin. Invest., 91: 1351-1357.
Kew, R.R., Hyers, T.M. and Webster, R.O. (1990) Human C-reactive protein inhibits neutrophil chemotaxis in vitro: possible implications for the adult respiratory distress syndrome.J. Lab. Clin. Med, 115: 339-349.
Heuertz, R.M., Xia, D., Samols, D. and Webster, R.O. (1992) Transgenic mice expressing plasma rabbit C-reactive protein exhibit diminished vascular permeability and neutrophil; infiltration in C5a-induced alveolitis.FASEB J., 6: 1064 (abstract).
Mold, C. and Gewurz, H. (1980) Activation of the alternative pathway by liposomes: inhibitory effect of C-reactive protein.Fed. Proc., 39: 702.
Mold, C. and Gewurz, H. (1981) Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes andStreptococcus pneumoniae. J. Immunol., 127: 2089-2092.
Gershov, D., Kim, S., Brot, N. and Elkon, K.B. (2000) C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity.J. Exp. Med, 192: 1353-1363.
Shine, B., de Beer, F.C. and Pepys, M.B. (1981) Solid phase radioimmunoass
Collison Angela M.
Frommer & Lawrence & Haug LLP
Kowalski Thomas J.
Pentraxin Therapeutics Limited
Wang Shengjun
LandOfFree
Treatment and prevention of tissue damage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment and prevention of tissue damage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment and prevention of tissue damage will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2804496